Drag a card by its title · ⚙ to size, swap or remove

The company

Sypris Solutions, Inc.

SYPR · Nasdaq

Health CareLife-science toolsNot moving yet

SYPR stood above a rising 150-day average in 32 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 29.0% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 20
Industry in uptrend: 52% +4 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $0
Officials’ trades on record: 1
Institutions holding: 25 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 32 of 52 weeks.

17 Apr – 16 Oct

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
James Comer House: U.S. House ClerkKY01	sold	$1k–$15k	28 Jul 2020filed 24 Aug 2020

Insiders

Buy orders, 12 months0

Sale orders, 12 months0

Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders25+0 on the quarter

New · exited6 · 6

Reported value$10.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Williams & Novak, LLCadded · filed 8 Jul 2026	2,205,929$5.4M	+72,628+3.4%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026	614,956$1.5M	-31,700−4.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	529,406$1.3M	+12,708+2.5%
Marex Group Ltdreduced · filed 14 Aug 2026	252,489$614K	-7,300−2.8%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	153,057$372K	-3,510−2.2%
BlackRock, Inc.added · filed 7 Aug 2026	74,911$182K	+12,152+19.4%
MARSHALL WACE, LLPnew · filed 13 Aug 2026	73,112$178K	+73,112
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	68,762$167K	+512+0.8%
LPL Financial LLCadded · filed 7 Aug 2026	68,300$166K	+8,800+14.8%
BRIDGEWAY CAPITAL MANAGEMENT, LLCunchanged · filed 14 Aug 2026	65,204$158K	00.0%

31 Mar 2023 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

Anthony C. Allen VP and Assistant Treasurer · last 2 Jul 20260 · 6

Curtis S. Petrie VP of Administration · last 2 Jul 20260 · 1

Jeffrey T. Gill President and CEO · last 2 Jul 20263 · 13

Rebecca R. Eckert VP, Chief Accounting Officer · last 2 Jul 20260 · 3

Richard L. Davis SVP and Treasurer · last 2 Jul 20262 · 12

Gary L. Convis Director · last 17 Jun 202622 · 0

R. Scott Gill Director, 10% owner · last 17 Jun 20262 · 0

Robert Sroka Director · last 17 Jun 20260 · 1

William G. Ferko Director · last 17 Jun 20262 · 0

William L. Healey Director · last 17 Jun 20260 · 0

John F. Brinkley Director · last 31 Jan 20240 · 0

Sidney R/ca Petersen Director · last 19 Oct 20210 · 3

Same industry

OABI OmniAbLeading+65%

TXG 10x GenomicsLeading+60%

AVTR AvantorLeading+47%

ILMN IlluminaLeading+44%

RVTY RevvityLeading+37%

CRL Charles River Laboratories InternationalLeading+35%

MASS 908 DevicesLeading+31%

IQV IQVIA HoldingsLeading+27%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 20257.8%

Operating profit marginFY 2025 · to 31 Dec 2025-5.5%

Free cash flow marginFY 2025 · to 31 Dec 2025-5.4%

Return on capital employedFY 2025 · to 31 Dec 2025-14.5%

Share count trendFY 2025 · to 10 Mar 20263.4%

Free cash flowFY 2025 · to 31 Dec 2025−$6.5M

Analyst forecasts

No analyst forecasts yet.